Overview

Ra Pharma® is a clinical-stage biopharmaceutical company using a proprietary peptide chemistry platform to develop novel therapeutics for the treatment of serious diseases that are caused by excessive or uncontrolled activation of the complement system, a critical component of the immune system.

NASDAQ RARX (Common Stock)
$10.26 - 0.29
Data provided by Nasdaq. Minimum 15 minutes delayed.
Stock chart for: RARX.O.  Currently trading at $10.26 with a 52 week high of $17.90 and a 52 week low of $4.78.

Recent News

Ra Pharmaceuticals Reports Second Quarter 2018 Financial Results and Announces Early Completion of Enrollment in gMG Phase 2 Program

Read More

View All News

Upcoming Event

There are currently no events scheduled.View All Events

Contact Us

Ra Pharmaceuticals, Inc.
87 Cambridge Park Drive
Cambridge, MA 02140
Phone: (617) 401-4060
Fax: (617) 401-4061

info@rapharma.com